Table 1 Patient and tumor characteristics (n = 100)
Age, years, median | 68 (43 – 88) |
|---|---|
Sex: m/f, n | 67 / 33 |
Weight loss > 5%/3 month, n (%) | 29 (29) |
Karnofsky Index, n (%) | |
100 | 14 (14) |
90 | 26 (26) |
80 | 37 (37) |
70 | 12 (12) |
60 | 9 (9) |
50 | 2 (2) |
COPD as comorbidity, n (%) | |
Grade 2 | 34 (34) |
3 | 17 (17) |
4 | 2 (2) |
Stage–grouping (UICC/ AJCC 8th edition), n (%) | |
II A | 2 (2) |
II B | 10(10) |
III A | 27 (27) |
III B | 43 (43) |
III C | 14 (14) |
IV A* | 4 (4) |
Histology/cytology, n (%) | |
Adenocarcinoma | 45 (45) |
Squamous cell carcinoma | 51 (51) |
NSC—n. o. s | 4 (4) |
Tumor localisation, n (%) | |
Central | 37 (37) |
Peripheral | 60 (60) |
Primary not detectable | 3 (3) |
Gross tumor volume, ccm, median (range) | |
Group 1 (n = 17) | 18 (4 – 47) |
Group 2 (n = 52) | 45 (12 – 218) |
Group 3 (n = 20) | 104 (46 – 255) |
Group 4 (n = 8) | 241 (189 – 387) |